Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Erbitux

(cetuximab)Orphan drugstandard

ImClone Systems Incorporated

Epidermal Growth Factor Receptor Antagonist [EPC]

12.1 Mechanism of Action The epidermal growth factor receptor (EGFR, HER1, c-ErbB-1) is a transmembrane glycoprotein that is a member of a subfamily o...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome.
Search all trials →

Search clinical trials for Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome →